MULTI-LINK VISION Coronary Stent System (U.S.)
The MULTI-LINK VISION Coronary Stent System is Abbott Vascular's first in a new class of cobalt chromium stents. Cobalt chromium is stronger and more radiopaque than stainless steel, so a cobalt chromium stent can have similar strength and visibility as a conventional stainless steel stent, with struts that are only .0032" thick. Thinner struts make the ML VISION stent extremely deliverable, and clinical research has shown that thinner struts are linked to lower restenosis rates.
Features
MULTI-LINK VISION: Powered to Perform with Cobalt Chromium
Abbott Vascular is recognized as the world leader in stent design and innovation. This leadership continues with the ML VISION stent—an entirely new class of cobalt chromium stents.
The ML VISION stent is laser cut from cobalt chromium, which allows us to reduce strut thickness and total stent volume while maintaining excellent radial strength and radiopacity.
The result? Our most flexible stent yet, with the best clinical outcomes we've ever delivered.
 see larger view |
Cobalt Chromium: Powering a New Class of Stents
This superalloy is proven biocompatible. It's stronger and more radiopaque than stainless steel¹, allowing for thinner struts without sacrificing radial strength or radiopacity.
 see larger view |
Superb Deliverability: Flexible, Low-Profile Design
The ML VISION stent offers superb flexibility and has the lowest profile available at just .040".2 This combination provides confidence to succeed, even in challenging cases.
 see larger view |
37% Thinner Struts: More Thinking, Less Metal
The ML VISION stent has the thinnest struts3–just .0032"–leading to less vessel injury* and extraordinary outcomes.
 see larger view |
Excellent Clinical Results: Clinically Driven TLR of 1.9%
The ML VISION stent proves its excellent performance with remarkable clinical data, including an impressive 6-month clinically driven TLR of 1.9%.4
- ASTM International. Data on file at Abbott Vascular.
- Tests performed by and data on file at Abbott Vascular.
- 3.0 x 18 mm stent as compared to the most commonly used workhorse stents on the U.S. market, 2003. Tests performed by and data on file at Abbott Vascular.
- Clinically driven TLR is defined in the VISION Registry as "Revascularization at the target site associated with any of the following: positve functional ischemia study, ischemic symptoms and an angiographic minimum lumen diameter stenosis ≥ 50% by QCA or revascularization of a target site with diameter stenosis ≥ 70% QCA without either angina or a positive functional study.
* As compared to ML Penta. Based on preclinical data on file at Abbott Vascular.
Specifications
MULTI-LINK VISION Part Numbers 31.7 KB
Instructions for Use
Instructions for Use (US Only)
LT2922560
